Vitality Watch

Dossier pubmed preclinical 15-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Lymphatic rarefaction drives cardiac inflammaging.

Key claim: Lymphatic rarefaction drives cardiac inflammaging.

Abstract

No abstract available.

Why this matters

Cardiac inflammaging has largely been mapped onto senescent cells, mtDNA leakage, and adipose/gut-derived signals; lymphatic drainage failure is a rarely invoked but mechanistically distinct clearance-side explanation for why inflammatory tone rises in the aging heart. If it holds up, lymphangiogenic interventions become a candidate lever that does not require silencing inflammation at its source. The claim is currently title-level preclinical, so it belongs on the trend-signal end of the mechanistic map, not the confirmed-driver end.

Source

Link

Briefing card

Lymphatic rarefaction drives cardiac inflammaging.
Stage: preclinical · pubmed · 15-sep-2026

Applies to researchers and clinicians tracking cardiac inflammaging: a lymphatic-drainage mechanism is now on the candidate list alongside senescence and mitochondrial DNA leakage, but the evidence is preclinical and title-level only.

Lymphatic rarefaction drives cardiac inflammaging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1038/s44161-026-00872-w

build build 880 · 2bcef25 · 2026-11-18